R. K. Ucgul Et Al. , "Intrastromal versus subconjunctival anti-VEGF agents for treatment of corneal neovascularization: a rabbit study," EYE , vol.35, no.11, pp.3123-3130, 2021
Ucgul, R. K. Et Al. 2021. Intrastromal versus subconjunctival anti-VEGF agents for treatment of corneal neovascularization: a rabbit study. EYE , vol.35, no.11 , 3123-3130.
Ucgul, R. K., Celebi, S., Yilmaz, N. S., BUKAN, N., & Ucgul, A. Y., (2021). Intrastromal versus subconjunctival anti-VEGF agents for treatment of corneal neovascularization: a rabbit study. EYE , vol.35, no.11, 3123-3130.
Ucgul, Rukiye Et Al. "Intrastromal versus subconjunctival anti-VEGF agents for treatment of corneal neovascularization: a rabbit study," EYE , vol.35, no.11, 3123-3130, 2021
Ucgul, Rukiye K. Et Al. "Intrastromal versus subconjunctival anti-VEGF agents for treatment of corneal neovascularization: a rabbit study." EYE , vol.35, no.11, pp.3123-3130, 2021
Ucgul, R. K. Et Al. (2021) . "Intrastromal versus subconjunctival anti-VEGF agents for treatment of corneal neovascularization: a rabbit study." EYE , vol.35, no.11, pp.3123-3130.
@article{article, author={Rukiye Kilic Ucgul Et Al. }, title={Intrastromal versus subconjunctival anti-VEGF agents for treatment of corneal neovascularization: a rabbit study}, journal={EYE}, year=2021, pages={3123-3130} }